Skip to main content
Equibles

Laura Shawver

Board Member

ARS Pharmaceuticals, Inc. (SPRY)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Laura Shawver

Laura Shawver is recorded as Board Member at ARS Pharmaceuticals, Inc. (SPRY). Laura Shawver was last confirmed as Board Member at Relay Therapeutics, Inc. (RLAY) in a filing dated April 14, 2022. ARS Pharmaceuticals, Inc. reported in an 8-K filed November 8, 2022 that Laura Shawver was appointed Class III Director, effective November 8, 2022. ARS Pharmaceuticals, Inc. reported in an 8-K filed July 21, 2022 that Laura Shawver resigned as CEO.

“At the effective time of the Merger, the Company's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
ARS Pharmaceuticals, Inc. Form 8-K, filed November 8, 2022 · Read the filing
“With respect to the management team for the combined company, I will step down as CEO upon close of the transaction and anticipate staying on as a member of the board of directors.”
ARS Pharmaceuticals, Inc. Form 8-K, filed July 21, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at ARS Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.